Research Division
Research & Technology
Viral Immunology Lab
Research Interests

The Viral Immunology Laboratory (VIL) aims to deeply understand immunological principles underlying responses to viral infections and vaccinations and ultimately develop preventive and therapeutic measures for immune-associated diseases including infectious diseases and cancers. In addition, studying molecular and cellular mechanisms of immuno-pathogenesis during respiratory viral infections such as influenza virus and SARS-CoV-2 (COVID-19 virus) are one of the current research topics. Especially, we are investigating how the innate immune system bolsters antibody and T cell responses, seeking to establish the bases for modulating the magnitude and longevity of immune protection. For a translational research axis, we are contributing to the development of advanced vaccine platforms including mRNA vaccines.

Our research interests can be summarized as follows:

• Immune responses and immunopathology triggered by influenza viruses and coronaviruses
• Investigation of efficacy and underlying mechanisms of vaccine and adjuvant
• Identification of novel immune-regulatory molecules using an innovative cell-based high throughput screening system



Eui Ho Kim, Ph.D.

  • Doctorate: University of Wisconsin-Madison (2014)
  • Post-Doctorate: Emory University (2014-2017) (PI: Bali Pulendran)
  • Research Fellow at NIEHS/NIH (2018)
  • CTO at NA Vaccine Institute (2019)
  • Head, Viral Immunology Lab, Institut Pasteur Korea (2020-Present)
  • Junghwa Lee

    Junghwa Lee, PhD


  • Sunmin Lee

    Sunmin Lee, PhD


  • Dongin Kim

    Dongin Kim, MS

  • Sujeong Lee

    Sujeong Lee, MS


  • Woochan Lee

    Woochan Lee


Selected Publications